These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 17695427

  • 1. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
    Miyoshi T, Kondo K, Toba H, Yoshida M, Fujino H, Kenzaki K, Sakiyama S, Takehisa M, Tangoku A.
    Anticancer Res; 2007; 27(4C):2641-8. PubMed ID: 17695427
    [Abstract] [Full Text] [Related]

  • 2. Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: relationship between mRNA expression and activity.
    Miyoshi T, Kondo K, Fujino H, Takahashi Y, Sawada N, Sakiyama S, Tsuyuguchi M, Kimura S, Sumitomo M, Monden Y.
    Anticancer Res; 2005; 25(2A):923-30. PubMed ID: 15868929
    [Abstract] [Full Text] [Related]

  • 3. Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer.
    Nakagawa T, Tanaka F, Takata T, Matsuoka K, Miyahara R, Otake Y, Yanagihara K, Fukushimab M, Wada H.
    J Surg Oncol; 2002 Oct; 81(2):87-92. PubMed ID: 12355409
    [Abstract] [Full Text] [Related]

  • 4. Effects of UFT on thymidylate synthase and dihydropyrimidine dehydrogenase activities in lung cancer.
    Miyamoto H, Morio A, Izumi H, Yamazaki A, Wang Z, Futagawa T, Sonobe S.
    Anticancer Res; 2003 Oct; 23(5b):4153-6. PubMed ID: 14666617
    [Abstract] [Full Text] [Related]

  • 5. Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU-based chemotherapy.
    Huang CL, Yokomise H, Kobayashi S, Fukushima M, Hitomi S, Wada H.
    Int J Oncol; 2000 Jul; 17(1):47-54. PubMed ID: 10853017
    [Abstract] [Full Text] [Related]

  • 6. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in tumor tissues and the efficacy of 5-fluorouracil in patients with non-small-cell lung cancer.
    Shintani Y, Ohta M, Hirabayashi H, Tanaka H, Iuchi K, Nakagawa K, Maeda H, Kido T, Miyoshi S, Matsuda H.
    Lung Cancer; 2004 Aug; 45(2):189-96. PubMed ID: 15246190
    [Abstract] [Full Text] [Related]

  • 7. Thymidylate synthase and dihydropyrimidine dehydrogenase expression levels are associated with response to S-1 plus carboplatin in advanced non-small cell lung cancer.
    Takeda M, Okamoto I, Hirabayashi N, Kitano M, Nakagawa K.
    Lung Cancer; 2011 Jul; 73(1):103-9. PubMed ID: 21111509
    [Abstract] [Full Text] [Related]

  • 8. Thymidylate synthase and dihydropyrimidine dehydrogenase expression in oral squamous cell carcinoma: an immunohistochemical and clinicopathologic study.
    Kawasaki G, Yoshitomi I, Yanamoto S, Mizuno A.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Dec; 94(6):717-23. PubMed ID: 12464897
    [Abstract] [Full Text] [Related]

  • 9. In vitro sensitivity to platinum-derived drugs is associated with expression of thymidylate synthase and dihydropyrimidine dehydrogenase in human lung cancer.
    Takizawa M, Kawakami K, Obata T, Matsumoto I, Ohta Y, Oda M, Sasaki T, Watanabe G.
    Oncol Rep; 2006 Jun; 15(6):1533-9. PubMed ID: 16685392
    [Abstract] [Full Text] [Related]

  • 10. [Thymidylate synthase and dihydropyrimidine dehydrogenase expression and histological effects of preoperative UFT in gastric cancer patients].
    Uyama R, Yoshizawa Y, Tajiri T, Endo Y, Mitsuya T, Sanada Y.
    Gan To Kagaku Ryoho; 2006 May; 33(5):625-9. PubMed ID: 16685161
    [Abstract] [Full Text] [Related]

  • 11. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M, Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan).
    Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
    [Abstract] [Full Text] [Related]

  • 12. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C.
    Oncology; 2006 Jul; 70(5):366-77. PubMed ID: 17179731
    [Abstract] [Full Text] [Related]

  • 13. [Relationships among the expression of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase and the prognosis of breast cancer].
    Yu ZG, Zhen JH, Jia HY, Zhang Q, Sun JZ.
    Zhonghua Yi Xue Za Zhi; 2006 Jun 13; 86(22):1558-63. PubMed ID: 16854285
    [Abstract] [Full Text] [Related]

  • 14. Expression of dihydropyrimidine dehydrogenase in cancer cells but not in stromal cells predicts the efficacy of fluorouracil treatment in patients with gastric carcinoma.
    Hisamitsu K, Tsujitani S, Yamaguchi K, Fukuda K, Konishi I, Kaibara N.
    Anticancer Res; 2004 Jun 13; 24(4):2495-501. PubMed ID: 15330204
    [Abstract] [Full Text] [Related]

  • 15. Role of dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine against non-small cell lung cancer--in correlation with the tumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase.
    Inoue K, Takao M, Watanabe F, Tarukawa T, Shimamoto A, Kaneda M, Sakai T, Fukushima M, Shimpo H, Yada I.
    Lung Cancer; 2005 Jul 13; 49(1):47-54. PubMed ID: 15949589
    [Abstract] [Full Text] [Related]

  • 16. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
    Ishida H, Yamada H, Shirakawa K, Nakada H, Ohsawa T, Takeuchi I, Okada N, Yokoyama M, Inokuma S, Suzuki T, Odaka A, Hoshino T, Murata N, Hashimoto D, Itoyama S, Mori T, Matsumoto Y, Miura T.
    Gan To Kagaku Ryoho; 2003 Oct 13; 30(11):1621-6. PubMed ID: 14619479
    [Abstract] [Full Text] [Related]

  • 17. Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase.
    Nio Y, Iguchi C, Kodama H, Itakura M, Hashimoto K, Koike M, Toga T, Maruyama R, Fukushima M.
    Oncol Rep; 2007 Jan 13; 17(1):153-9. PubMed ID: 17143493
    [Abstract] [Full Text] [Related]

  • 18. Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy.
    Toi M, Ikeda T, Akiyama F, Kurosumi M, Tsuda H, Sakamoto G, Abe O.
    Int J Oncol; 2007 Oct 13; 31(4):899-906. PubMed ID: 17786323
    [Abstract] [Full Text] [Related]

  • 19. [Immunohistochemical and clinicopathological study of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyl transferase expression in oral cancer patients responding to UFT].
    Kawasaki G, Yoshitomi I, Yanamoto S, Yamada S, Kawano T, Mizuno A.
    Gan To Kagaku Ryoho; 2010 Jun 13; 37(6):1035-9. PubMed ID: 20567103
    [Abstract] [Full Text] [Related]

  • 20. Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
    Ichikawa W, Uetake H, Shirota Y, Yamada H, Nishi N, Nihei Z, Sugihara K, Hirayama R.
    Clin Cancer Res; 2003 Feb 13; 9(2):786-91. PubMed ID: 12576451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.